Journal of Affective Disorders
Volume 65, Issue 2 , Pages 117-122 , July 2001

Is lithium response related to Gsα levels in transformed lymphoblasts from subjects with bipolar disorder?

  • Martin Alda

      Affiliations

    • Department of Psychiatry, Dalhousie University, Halifax, Canada
    • Department of Psychiatry, University of Ottawa, Ottawa, Canada
    • ,
  • Dan Keller

      Affiliations

    • Department of Psychiatry and Behavioural Neurosciences, McMaster University, HSC-4N77A, 1200 Main St. W., Hamilton, Ontario, Canada
    • ,
  • Eva Grof

      Affiliations

    • Department of Psychiatry, University of Ottawa, Ottawa, Canada
    • ,
  • Gustavo Turecki

      Affiliations

    • Centre for Research in Neuroscience, McGill University, Montreal, Canada
    • ,
  • Patrizia Cavazzoni

      Affiliations

    • Department of Psychiatry, University of Ottawa, Ottawa, Canada
    • ,
  • Anne Duffy

      Affiliations

    • Department of Psychiatry, Dalhousie University, Halifax, Canada
    • ,
  • Guy A Rouleau

      Affiliations

    • Centre for Research in Neuroscience, McGill University, Montreal, Canada
    • ,
  • Paul Grof

      Affiliations

    • Department of Psychiatry, University of Ottawa, Ottawa, Canada
    • ,
  • L.Trevor Young

      Affiliations

    • Department of Psychiatry and Behavioural Neurosciences, McMaster University, HSC-4N77A, 1200 Main St. W., Hamilton, Ontario, Canada
    • Corresponding Author InformationCorresponding author. Tel.: +1-905-525-9140, ext. 22501; fax: +1-905-522-8804

Received 1 October 1999 ,Accepted 5 January 2000.

References 

  1. Anderson MA, Gusella JF. Use of cyclosporin H in establishing Epstein–Barr virus-transformed human lymphoblastoid cell lines. In Vitro. 1984;20:856–858
  2. Avissar S, Schreiber G, Danon A, Belmaker RH. Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature. 1988;331:440–442
  3. Avissar S, Barki-Harrington L, Nechamkin Y, Roitman G, Schreiber G. Reduced β-adrenergic receptor-coupled Gs protein function and Gs immunoreactivity in mononuclear leukocytes of patients with depression. Biol. Psychiatry. 1996;39:755–760
  4. Avissar S, Nechamkiin Y, Barki-Harrington L, Roitman G, Schreiber G. Differential G protein measures in mononuclear leukocytes of patients with bipolar mood disorder are state dependent. J. Affect. Disord. 1997;43:85–93
  5. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976;72:248–252
  6. Colin SF, Chang HC, Mollner S, Pfeuffer T, Reed RR, Duman RS, et al.  Chronic lithium regulates the expression of adenylyl cyclase Gi-protein a subunit in rat cerebral cortex. Proc. Natl. Acad. Sci. USA. 1991;88:10634–10637
  7. Dowlatshahi D, MacQueen GM, Wang JF, Reiach JS, Young LT. G-protein coupled cAMP signalling in mood disorders: effects of diagnosis, treatment at the time of death and suicide. J. Neurochem. 1999;73:1121–1126
  8. Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch. Gen. Psychiatry. 1978;35:773–782
  9. Friedman E, Wang HY. Receptor mediated activation of G proteins is increased in postmortem brains of bipolar affective disorder subjects. J. Neurochem. 1996;67:1145–1152
  10. Gejman PV, Martinez M, Cao QH, Friedman E, Berrettini WH, Goldin LR, et al. Linkage analysis of fifty-seven microsatellite loci to bipolar disorder. Neuropsychopharmacology. 1993;9:31–40
  11. Grof P, Alda M, Grof E, Zvolsky P, Walsh M. Lithium response and genetics of affective disorders. J. Affect. Disord. 1994;32:85–95
  12. Jope RS. Anti-bipolar therapy: mechanism of action of lithium. Mol. Psychiatry. 1999;4:117–128
  13. Le F, Mitchell PB, Vivero C, Waters B, Donald J, Selbie LA, et al. Exclusion of close linkage of bipolar disorder to the Gs-α subunit gene in nine Australian pedigrees. J. Affect. Disord. 1994;32:187–195
  14. Li X, Jope RS. Selective inhibition of the expression of signal transduction proteins by lithium in nerve growth factor-differentiated PC12 cells. J. Neurochem. 1995;65(6):2500–2508
  15. Li PP, Young LT, Warsh JJ. Lithium decreases Gs, Gi-1 and Gi-2 α-subunit mRNA levels in rat cortex. Eur. J. Pharmacol. 1991;206:165–166
  16. Li PP, Young LT, Tam YK, Sibony D, Warsh JJ. Effects of chronic lithium and carbamazepine treatment on G protein subunit expression in rat cortex. Biol. Psychiatry. 1993;34:167–170
  17. Manji HK, Chen G, Shimon H, Hsiao JK, Potter WZ, Belmaker RH. Guanine nucleotide-binding proteins in bipolar affective disorder: effects of long-term lithium treatment. Arch. Gen. Psychiatry. 1995;52:135–144
  18. Mitchell PB, Manji HK, Chen G, Jolkovsky L, Smith-Jackson E, Denicott K, et al. High levels of Gs alpha in platelets of euthymic patients with bipolar affective disorder. Am. J. Psychiatry. 1997;154(2):218–223
  19. Mork A, Geisler A. Effects of lithium ex vivo on the GTP-mediated inhibition of calcium-stimulated adenylyl cyclase activity in rat brain. Eur. J. Pharmacol. 1989;168:347–354
  20. Mork A, Geisler A. Effects of GTP on hormone-stimulated adenylyl cyclase activity in cerebral cortex, striatum and hippocampus from rats treated chronically with lithium. Biol. Psychiatry. 1989;26:279–288
  21. Perez J, Zanardi R, Mori S, Gasperini M, Smeraldi E, Racagni G. Abnormalities of cAMP-dependent endogenous phosphorylation in platelets from patients with bipolar disorder. Am. J. Psychiatry. 1995;152(8):1204–1206
  22. Rahman S, Li PP, Young LT, Kofman O, Kish SJ, Warsh JJ. Reduced 3H cAMP binding in postmortem brain from subjects with bipolar affective disorder. J. Neurochem. 1997;68(1):297–304
  23. Risby ED, Hsiao JK, Manji HK, Bitran J, Moses F, Zhou DF, et al.  The mechanisms of action of lithium. II. Effects on adenylate cyclase activity and beta-adrenergic receptor binding in normal subjects. Arch. Gen. Psychiatry. 1991;48(6):513–524
  24. Schreiber G, Avissar S, Danon A, Belmaker RH. Hyperfunctional G proteins in mononuclear leukocytes of patients with mania. Biol. Psychiatry. 1991;29:273–280
  25. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria: rationale and reliability. Arch. Gen. Psychiatry. 1978;35:773–782
  26. Turecki G, Grof P, Cavazzoni P, Duffy A, Grof E, Ahrens B, et al. Evidence for a role of phospholipase C-gamma 1 in the pathogenesis of bipolar disorder. Mol. Psychiatry. 1998;3:534–538
  27. Wang JF, Asghari V, Rockel C, Young LT. Cyclic AMP responsive element binding protein phosphorylation and DNA binding is decreased by chronic lithium but not valproate treatment of SH-SY5Y neuroblastoma cells. Neuroscience. 1999;91(2):771–776
  28. Young LT, Li PP, Kish SJ, Siu LP, Warsh JJ. Postmortem cerebral cortex Gs alpha-subunit levels are elevated in bipolar affective disorder. Brain Res. 1991;551:323–326
  29. Young LT, Li PP, Kish SJ, Siu KP, Kamble A, Hornykiewicz O, et al. Cerebral cortex Gsα protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. J. Neurochem. 1993;61:890–898
  30. Young LT, Li PP, Kamble A, Siu KP, Warsh JJ. Mononuclear leukocyte levels of G-proteins in depressed patients with bipolar disorder or major depressive disorder. Am. J. Psychiatry. 1994;151:594–596
  31. Young LT, Asghari V, Li PP, Kish SJ, Fahnestock M, Warsh JJ. Stimulatory G-protein alpha-subunit mRNA levels are not increased in autopsied cerebral cortex from patients with bipolar disorder. Brain Res. 1996;42(1):45–50

PII: S0165-0327(00)00166-X

Journal of Affective Disorders
Volume 65, Issue 2 , Pages 117-122 , July 2001

Article Tools

* Image Usage & Resolution